Clinical · 8 August 2026

NHS Bowel Screening Finds 100 Cancers Weekly in Over-50s

NHS England data for 2024–25 shows bowel cancer screening detects around 100 cancers per week among people in their 50s, yet uptake in this group remains low.

NHS England has published its latest annual bowel cancer screening statistics, covering the period from April 2024 to March 2025, and the results have prompted a renewed public health appeal directed at people in their 50s. The data reveal that screening tests are identifying roughly 100 cancers per week among this demographic — yet participation within the age group remains lower than health officials would like.

Uptake Among Those in Their 50s Falls Short

According to the NHS England figures, just 56.2% of 54-year-olds completed bowel cancer screening during the reported year. That means nearly half of people at this age who were sent a home testing kit did not return it — a pattern that health officials say represents a significant missed opportunity for early detection.

The screening programme sends home kits that allow individuals to collect a small stool sample, which is then analysed for traces of blood that may not be visible to the naked eye. When abnormalities are detected, further investigation can follow. The process is designed to catch cancers or pre-cancerous changes before symptoms develop, when treatment outcomes are generally more favourable.

Why the 50s Matter for Screening

The NHS extended bowel cancer screening eligibility to people in their 50s in recent years as part of efforts to detect the disease at earlier, more treatable stages. The latest statistics suggest this expansion is yielding results — approximately 100 cancers per week are being found among people in this age bracket through the programme — but only among those who actually return their kits.

The gap between what screening is finding and what it could potentially find, if uptake were higher, is a central concern in the NHS England announcement. Lower participation rates mean that a substantial portion of cancers in this group may go undetected until symptoms appear, often at a more advanced stage.

Barriers to Participation

Research into screening behaviour has consistently identified several factors that reduce the likelihood of kit completion. These include discomfort with the testing process, a lack of awareness about the programme, and a tendency among people who feel well to deprioritise preventive health measures. People in their 50s, who may be managing work and family responsibilities, are sometimes less likely to engage with health screening than older age groups who have had more exposure to such programmes over time.

NHS England's public appeal is aimed at addressing some of these barriers by reinforcing the message that the test is straightforward to complete at home and that the detection rates justify the effort involved.

What the Figures Represent

The statistic of around 100 cancers detected per week among people in their 50s reflects the programme's reach across a large population. It also underscores the scale of bowel cancer as a public health concern. Early-stage bowel cancer is associated with significantly better survival outcomes than cancer diagnosed at a later stage, which is the core rationale behind population-level screening programmes of this kind.

NHS England's annual bowel screening data serve as a barometer for how well the programme is functioning and where efforts to improve uptake should be concentrated. The 2024–25 figures make clear that people in their 50s represent a priority group for engagement, given both the detection rates already being achieved and the headroom that exists if more individuals in this cohort were to participate.

The home testing kits are sent automatically to eligible individuals. Those who have received a kit and not yet returned it can do so by post using the prepaid packaging included with the test.

References

  1. NHS urges people in their 50s to return bowel screening kits as 100 cancers found a week NHS England
This is news reporting and is not medical advice. For medical questions, consult a doctor.